Skip to main content
Top
Published in: Surgery Today 4/2013

01-04-2013 | Original Article

Chest-tube drainage is a sign of acute exacerbation of interstitial lung disease associated with lung cancer

Authors: Tomohiro Maniwa, Mitsuhiro Isaka, Kazuo Nakagawa, Yasuhisa Ohde, Takehiro Okumura, Masahiro Endo, Haruhiko Kondo

Published in: Surgery Today | Issue 4/2013

Login to get access

Abstract

Purpose

Interstitial lung disease (ILD) is associated with primary lung cancer and an increased risk of postoperative acute exacerbation (AE). Although the preoperative factors associated with AE of ILD are well described, there is little information about the postoperative factors. Thus, the present study focuses on the postoperative management of chest-tube drainage associated with AE of ILD.

Methods

We conducted a retrospective chart study of 1,309 patients with lung cancer, who underwent pulmonary resection at Shizuoka Cancer Center between September 2002 and January 2011. ILD was diagnosed by chest computed tomography (CT) findings in 95 patients. After the exclusion of 6 patients with a history of pneumonectomy, the subjects of this study were 8 patients who suffered AE after surgery (AE group) and 81 patients (non-AE group) who did not. We investigated the clinicopathological findings and postoperative management of chest-tube drainage in the two groups.

Results

The clinicopathological findings of the two groups did not differ significantly. The chest tubes could not be removed before postoperative day 5 because of pleural effusion in 5 patients (62.5 %) from the AE group and 12 patients (14.8 %) from the non-AE group (P = 0.0040).

Conclusions

The postoperative volume draining from the chest-tube is an important sign of AE of ILD.
Literature
1.
go back to reference King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005;172:268–79.PubMedCrossRef King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005;172:268–79.PubMedCrossRef
2.
go back to reference Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg. 2003;125:1321–7.PubMedCrossRef Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg. 2003;125:1321–7.PubMedCrossRef
3.
go back to reference Chiyo M, Sekine Y, Iwata T, Tatsumi K, Yasufuku K, Iyoda A, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg. 2003;126:1141–6.PubMedCrossRef Chiyo M, Sekine Y, Iwata T, Tatsumi K, Yasufuku K, Iyoda A, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg. 2003;126:1141–6.PubMedCrossRef
4.
go back to reference Shintani Y, Ohta M, Iwasaki T, Ikeda N, Tomita E, Kawahara K, et al. Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer. Gen Thorac Cardiovasc Surg. 2010;58:182–5.PubMedCrossRef Shintani Y, Ohta M, Iwasaki T, Ikeda N, Tomita E, Kawahara K, et al. Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer. Gen Thorac Cardiovasc Surg. 2010;58:182–5.PubMedCrossRef
5.
go back to reference Koizumi K, Hirata T, Hirai K, Mikami I, Okada D, Yamagishi S, et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg. 2004;10:340–6.PubMed Koizumi K, Hirata T, Hirai K, Mikami I, Okada D, Yamagishi S, et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg. 2004;10:340–6.PubMed
6.
go back to reference Park JS, Kim HK, Kim K, Kim J, Shim YM, Choi YS. Prediction of acute pulmonary complications after resection of lung cancer in patients with preexisting interstitial lung disease. Thorac Cardiovasc Surg. 2011;59:148–52.PubMedCrossRef Park JS, Kim HK, Kim K, Kim J, Shim YM, Choi YS. Prediction of acute pulmonary complications after resection of lung cancer in patients with preexisting interstitial lung disease. Thorac Cardiovasc Surg. 2011;59:148–52.PubMedCrossRef
7.
go back to reference Muraoka M, Tagawa T, Akamine S, Oka T, Tsuchiya T, Araki M, et al. Acute interstitial pneumonia following surgery for primary lung cancer. Eur J Cardiothorac Surg. 2006;30:657–62.PubMedCrossRef Muraoka M, Tagawa T, Akamine S, Oka T, Tsuchiya T, Araki M, et al. Acute interstitial pneumonia following surgery for primary lung cancer. Eur J Cardiothorac Surg. 2006;30:657–62.PubMedCrossRef
8.
go back to reference Ito H, Nakayama H, Tsuboi M, Kameda Y, Yokose T, Hasegawa C, et al. Subpleural honeycombing on high resolution computed tomography is risk factor for fatal pneumonitis. Ann Thorac Surg. 2011;91:874–8.PubMedCrossRef Ito H, Nakayama H, Tsuboi M, Kameda Y, Yokose T, Hasegawa C, et al. Subpleural honeycombing on high resolution computed tomography is risk factor for fatal pneumonitis. Ann Thorac Surg. 2011;91:874–8.PubMedCrossRef
9.
go back to reference Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132:1652–8.PubMedCrossRef Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132:1652–8.PubMedCrossRef
10.
go back to reference Coalson JJ. The ultrastructure of human fibrosing alveolitis. Virchows Arch A Pathol Anat Histol. 1982;395:181–99.PubMedCrossRef Coalson JJ. The ultrastructure of human fibrosing alveolitis. Virchows Arch A Pathol Anat Histol. 1982;395:181–99.PubMedCrossRef
11.
go back to reference Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med. 2003;167:438–43.PubMedCrossRef Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med. 2003;167:438–43.PubMedCrossRef
12.
go back to reference Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2004;169:1203–8.PubMedCrossRef Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2004;169:1203–8.PubMedCrossRef
13.
go back to reference Yamashita M, Iwama N, Date F, Chiba R, Ebina M, Miki H, et al. Characterization of lymphangiogenesis in various stages of idiopathic diffuse alveolar damage. Hum Pathol. 2009;40:542–51.PubMedCrossRef Yamashita M, Iwama N, Date F, Chiba R, Ebina M, Miki H, et al. Characterization of lymphangiogenesis in various stages of idiopathic diffuse alveolar damage. Hum Pathol. 2009;40:542–51.PubMedCrossRef
14.
go back to reference Yamashita M, Yamauchi K, Chiba R, Iwama N, Date F, Shibata N, et al. The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices. Hum Pathol. 2009;40:1278–87.PubMedCrossRef Yamashita M, Yamauchi K, Chiba R, Iwama N, Date F, Shibata N, et al. The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices. Hum Pathol. 2009;40:1278–87.PubMedCrossRef
15.
go back to reference Ebina M, Shibata N, Ohta H, Hisata S, Tamada T, Ono M, et al. The disappearance of subpleural and interlobular lymphatics in idiopathic pulmonary fibrosis. Lymphat Res Biol. 2010;8:199–207.PubMedCrossRef Ebina M, Shibata N, Ohta H, Hisata S, Tamada T, Ono M, et al. The disappearance of subpleural and interlobular lymphatics in idiopathic pulmonary fibrosis. Lymphat Res Biol. 2010;8:199–207.PubMedCrossRef
16.
go back to reference Blivet S, Philit F, Sab JM, Langevin B, Paret M, Guérin C, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest. 2001;120:209–12.PubMedCrossRef Blivet S, Philit F, Sab JM, Langevin B, Paret M, Guérin C, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest. 2001;120:209–12.PubMedCrossRef
17.
go back to reference Stern JB, Mal H, Groussard O, Brugière O, Marceau A, Jebrak G, et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest. 2001;120:213–9.PubMedCrossRef Stern JB, Mal H, Groussard O, Brugière O, Marceau A, Jebrak G, et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest. 2001;120:213–9.PubMedCrossRef
18.
go back to reference Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993;103:1808–12. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993;103:1808–12.
19.
go back to reference Nishiyama O, Shimizu M, Ito Y, Kume H, Suzuki R, Yokoi T, et al. Effect of prolonged low-dose methylprednisolone therapy in acute exacerbation of idiopathic pulmonary fibrosis. Respir Care. 2001;46:698–701.PubMed Nishiyama O, Shimizu M, Ito Y, Kume H, Suzuki R, Yokoi T, et al. Effect of prolonged low-dose methylprednisolone therapy in acute exacerbation of idiopathic pulmonary fibrosis. Respir Care. 2001;46:698–701.PubMed
20.
go back to reference Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg. 2005;79:405–10.PubMedCrossRef Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg. 2005;79:405–10.PubMedCrossRef
Metadata
Title
Chest-tube drainage is a sign of acute exacerbation of interstitial lung disease associated with lung cancer
Authors
Tomohiro Maniwa
Mitsuhiro Isaka
Kazuo Nakagawa
Yasuhisa Ohde
Takehiro Okumura
Masahiro Endo
Haruhiko Kondo
Publication date
01-04-2013
Publisher
Springer Japan
Published in
Surgery Today / Issue 4/2013
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-012-0428-x

Other articles of this Issue 4/2013

Surgery Today 4/2013 Go to the issue